Discover 2,356 paid clinical trials in Oceanside, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,356
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
for
Lung Neoplasm
Location: Long Beach CA, West Los Angeles CA, Houston TX,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT02984761
Recruiting
Atrial Fibrillation Ablation Registry
for
Atrial Fibrillation
Location: Newport Beach CA
Sponsor: Hoag Memorial Hospital Presbyterian
Sex: All
Age: 18+
Code: NCT04055961
Recruiting
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer (NSCLC)
Location: San Diego CA, Irvine CA, Fountain Valley CA,
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT07288177
Phase 2, Recruiting
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
for
Cancer, Melanoma Stage III, Melanoma Stage IV,
Location: Rancho Santa Margarita CA, Los Angeles CA, Omaha NE,
Sponsor: Krystal Biotech, Inc.
Sex: All
Age: 18+
Code: NCT05970497
Phase 1, Phase 2, Recruiting
Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis
for
Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
Location: San Diego CA, Colorado Springs CO, Fort Worth TX,
Sponsor: Airiver Medical, Inc.
Sex: All
Age: 18+
Code: NCT07290140
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)
for
Long Term Follow-up
Location: San Diego CA, Hillsborough NJ
Sponsor: Arbutus Biopharma Corporation
Sex: All
Age: 20 - 70
Code: NCT06277037
Recruiting
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
for
Systemic Lupus Erythematosus, Lupus Nephritis
Location: Orange CA, Sacramento CA, Houston TX, Kansas City KS,
Sponsor: Cabaletta Bio
Sex: All
Age: 12 - 65
Code: NCT06121297
Phase 1, Phase 2, Recruiting
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Irvine CA, Los Angeles CA, Seattle WA, Charlotte NC,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06697197
Phase 1, Phase 2, Recruiting
Study of the Use of Laser Light to Treat Osteoarthritis of the Hand.
for
Osteoarthritis
Location: Long Beach CA, Phoenix AZ, Bloomington MN
Sponsor: TriTech Manufacturing
Sex: All
Age: 18+
Code: NCT00254111
Recruiting
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
for
Alopecia Areata
Location: San Diego CA, Palm Springs CA, Los Angeles CA,
Sponsor: Sun Pharmaceutical Industries, Inc.
Sex: All
Age: 12 - 17
Code: NCT07133308
Phase 3, Recruiting
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
for
Heart Failure
Location: San Diego CA, Newport Beach CA, Covina CA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06935370
Phase 3, Recruiting
Neural Basis of Social Cognition Deficits
for
Autism Spectrum Disorder, Psychosis, Social Communication
Location: Loma Linda CA
Sponsor: Loma Linda University
Sex: All
Age: 12 - 18
Code: NCT05185128
Recruiting
A Global Prospective Observational Registry of Patients With Pompe Disease
for
Pompe Disease
Location: Irvine CA, Salt Lake City UT, Little Rock AR,
Sponsor: Amicus Therapeutics
Sex: All
Age: 0+
Code: NCT06121011
Recruiting
Philips FAST SpO2 Technology With Masimo Sensors for SpO2 Monitoring in the Neonatal, Infant, and Pediatric Populations
for
SpO2
Location: San Diego CA, Modesto CA
Sponsor: Masimo Corporation
Sex: All
Age: 0 - 21
Code: NCT07223177
Recruiting
Regeneron AA Multicenter (Dupilumab)
for
Alopecia Areata
Location: Irvine CA, Rochester NY, New York NY
Sponsor: Emma Guttman
Sex: All
Age: 18+
Code: NCT05551793
Phase 2, Recruiting
First in Human Study of TORL-1-23 in Participants With Advanced Cancer